The finding that the knock-in of the Alzheimer’s disease-linked London mutation in APP in in vitro differentiated human neurons also resulted in a drop in TTL compared to isogenic controls strongly supports a causal relationship between TTL loss and familial Alzheimer’s disease. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.